ENvue Medical (FEED) Net Cash Flow Growth (3y) (2017 - 2026)
ENvue Medical (FEED) Net Cash Flow Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 269.22% |
| 10 | ENvue Medical | 2.53 Mn | 1.38 Mn | -266,000.00 | 2.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.93% |
| Mar 31, 2026 | -18.54% |
| Dec 31, 2025 | -27.13% |
| Sep 30, 2025 | 51.63% |
| Jun 30, 2025 | 55.12% |
| Mar 31, 2025 | 55.83% |
| Dec 31, 2024 | 14.05% |
| Sep 30, 2024 | -31.90% |
| Jun 30, 2024 | 37.78% |
| Mar 31, 2024 | -48.71% |
| Dec 31, 2023 | -28.56% |
| Sep 30, 2023 | 2.01% |
| Jun 30, 2023 | -36.52% |
| Mar 31, 2023 | -10.08% |
| Dec 31, 2022 | -13.07% |
| Sep 30, 2022 | -159.12% |
| Jun 30, 2022 | -42.83% |
| Mar 31, 2022 | -34.72% |
| Dec 31, 2021 | -1.27% |
| Sep 30, 2021 | 78.83% |